Nova Mentis Life Science (TSE:NOVA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Nova Mentis Life Science Corp. has announced an agreement to assign its intellectual property related to the mRNA Neuro Panel and Serotonin Assay to Ludwig Enterprises Inc. The deal includes debt forgiveness, stock issuance, and future royalties on commercialized revenue for NOVA. Amidst challenges in its Phase 2a clinical trial and the broader psychedelic sector, NOVA is seeking new business opportunities to enhance shareholder value.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.
